A citation-based method for searching scientific literature

Charles D Burger, Pamela K Long, Monarch R Shah, Michael D McGoon, Dave P Miller, Alain J Romero, Wade W Benton, Robert E Safford. Chest 2014
Times Cited: 54







List of co-cited articles
221 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Nazzareno Galiè, Joan A Barberà, Adaani E Frost, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Vallerie V McLaughlin, Andrew J Peacock, Gérald Simonneau, Jean-Luc Vachiery, Ekkehard Grünig,[...]. N Engl J Med 2015
642
42


Selexipag for the Treatment of Pulmonary Arterial Hypertension.
Olivier Sitbon, Richard Channick, Kelly M Chin, Aline Frey, Sean Gaine, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Irene M Lang, Ralph Preiss,[...]. N Engl J Med 2015
515
35

Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Tomás Pulido, Igor Adzerikho, Richard N Channick, Marion Delcroix, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Pavel Jansa, Zhi-Cheng Jing, Franck-Olivier Le Brun, Sanjay Mehta,[...]. N Engl J Med 2013
823
29

Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
Noam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, Tracy Waldman, Vijay Joish, Todd Williamson. Appl Health Econ Health Policy 2011
39
35


An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Raymond L Benza, Dave P Miller, Robyn J Barst, David B Badesch, Adaani E Frost, Michael D McGoon. Chest 2012
654
24

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients.
Mirko Sikirica, Serban R Iorga, Tim Bancroft, Jesse Potash. BMC Health Serv Res 2014
56
24

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, Robert P Frantz, Aimee J Foreman, Christopher S Coffey, Adaani Frost, Robyn J Barst, David B Badesch, C Gregory Elliott,[...]. Circulation 2010
22

Five-Year outcomes of patients enrolled in the REVEAL Registry.
Harrison W Farber, Dave P Miller, Abby D Poms, David B Badesch, Adaani E Frost, Erwan Muros-Le Rouzic, Alain J Romero, Wade W Benton, C Gregory Elliott, Michael D McGoon,[...]. Chest 2015
255
22

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
Vallerie V McLaughlin, Marius M Hoeper, Richard N Channick, Kelly M Chin, Marion Delcroix, Sean Gaine, Hossein-Ardeschir Ghofrani, Pavel Jansa, Irene M Lang, Sanjay Mehta,[...]. J Am Coll Cardiol 2018
58
22

Updated treatment algorithm of pulmonary arterial hypertension.
Nazzareno Galiè, Paul A Corris, Adaani Frost, Reda E Girgis, John Granton, Zhi Cheng Jing, Walter Klepetko, Michael D McGoon, Vallerie V McLaughlin, Ioana R Preston,[...]. J Am Coll Cardiol 2013
449
20

Updated clinical classification of pulmonary hypertension.
Gerald Simonneau, Michael A Gatzoulis, Ian Adatia, David Celermajer, Chris Denton, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, R Krishna Kumar, Michael Landzberg, Roberto F Machado,[...]. J Am Coll Cardiol 2013
20


Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
Raymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, Harrison W Farber, Aimee J Foreman, Adaani E Frost, Michael D McGoon, David J Pasta, Mona Selej, Charles D Burger,[...]. Chest 2019
248
20

Riociguat for the treatment of pulmonary arterial hypertension.
Hossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi-Cheng Jing, Anne M Keogh, David Langleben, Michael Ochan Kilama, Arno Fritsch,[...]. N Engl J Med 2013
804
18


Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau, David Montani, David S Celermajer, Christopher P Denton, Michael A Gatzoulis, Michael Krowka, Paul G Williams, Rogerio Souza. Eur Respir J 2019
18

Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
Nazzareno Galiè, Gérald Simonneau, Robyn J Barst, David Badesch, Lewis Rubin. Curr Opin Pulm Med 2010
33
27

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.
David B Badesch, Gary E Raskob, C Greg Elliott, Abby M Krichman, Harrison W Farber, Adaani E Frost, Robyn J Barst, Raymond L Benza, Theodore G Liou, Michelle Turner,[...]. Chest 2010
753
16

Effect of macitentan on hospitalizations: results from the SERAPHIN trial.
Richard N Channick, Marion Delcroix, Hossein-Ardeschir Ghofrani, Elke Hunsche, Pavel Jansa, Franck-Olivier Le Brun, Sanjay Mehta, Tomás Pulido, Lewis J Rubin, B K S Sastry,[...]. JACC Heart Fail 2015
48
18

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Marius M Hoeper, Tilmann Kramer, Zixuan Pan, Christina A Eichstaedt, Jens Spiesshoefer, Nicola Benjamin, Karen M Olsson, Katrin Meyer, Carmine Dario Vizza, Anton Vonk-Noordegraaf,[...]. Eur Respir J 2017
347
16


The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Adaani E Frost, David B Badesch, Robyn J Barst, Raymond L Benza, C Gregory Elliott, Harrison W Farber, Abby Krichman, Theodore G Liou, Gary E Raskob, Prieya Wason,[...]. Chest 2011
214
14

An epidemiological study of pulmonary arterial hypertension.
A J Peacock, N F Murphy, J J V McMurray, L Caballero, S Stewart. Eur Respir J 2007
510
14



Pulmonary arterial hypertension in France: results from a national registry.
Marc Humbert, Olivier Sitbon, Ari Chaouat, Michèle Bertocchi, Gilbert Habib, Virginie Gressin, Azzedine Yaici, Emmanuel Weitzenblum, Jean-François Cordier, François Chabot,[...]. Am J Respir Crit Care Med 2006
12

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.
Harrison W Farber, Dave P Miller, Michael D McGoon, Adaani E Frost, Wade W Benton, Raymond L Benza. J Heart Lung Transplant 2015
76
12

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.
Yi Ling, Martin K Johnson, David G Kiely, Robin Condliffe, Charlie A Elliot, J Simon R Gibbs, Luke S Howard, Joanna Pepke-Zaba, Karen K K Sheares, Paul A Corris,[...]. Am J Respir Crit Care Med 2012
366
12

Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension.
François Haddad, Tyler Peterson, Eric Fuh, Kristina T Kudelko, Vinicio de Jesus Perez, Mehdi Skhiri, Randall Vagelos, Ingela Schnittger, Andre Y Denault, David N Rosenthal,[...]. Circ Heart Fail 2011
76
12


Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
Mallik Angalakuditi, Eric Edgell, Anthony Beardsworth, Erin Buysman, Tim Bancroft. J Med Econ 2010
32
21

Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
Charles D Burger, A Burak Ozbay, Howard M Lazarus, Ellen Riehle, Leslie B Montejano, Gregory Lenhart, R James White. J Manag Care Spec Pharm 2018
21
33

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.
Marc Humbert, Olivier Sitbon, Ari Chaouat, Michèle Bertocchi, Gilbert Habib, Virginie Gressin, Azzedine Yaïci, Emmanuel Weitzenblum, Jean-François Cordier, François Chabot,[...]. Circulation 2010
11

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
Vallerie V McLaughlin, Raymond L Benza, Lewis J Rubin, Richard N Channick, Robert Voswinckel, Victor F Tapson, Ivan M Robbins, Horst Olschewski, Melvyn Rubenfire, Werner Seeger. J Am Coll Cardiol 2010
371
11

End points and clinical trial design in pulmonary arterial hypertension.
Vallerie V McLaughlin, David B Badesch, Marion Delcroix, Thomas R Fleming, Sean P Gaine, Nazzareno Galiè, J Simon R Gibbs, Nick H Kim, Ronald J Oudiz, Andrew Peacock,[...]. J Am Coll Cardiol 2009
175
11

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Hossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, Marius M Hoeper, Pavel Jansa, Nick H Kim, Eckhard Mayer, Gerald Simonneau, Martin R Wilkins, Arno Fritsch,[...]. N Engl J Med 2013
792
11

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
Olivier Sitbon, Xavier Jaïs, Laurent Savale, Vincent Cottin, Emmanuel Bergot, Elise Artaud Macari, Hélène Bouvaist, Claire Dauphin, François Picard, Sophie Bulifon,[...]. Eur Respir J 2014
222
11

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
Victor F Tapson, Zhi-Cheng Jing, Kai-Feng Xu, Lei Pan, Jeremy Feldman, David G Kiely, Eugene Kotlyar, C Shane McSwain, Kevin Laliberte, Carl Arneson,[...]. Chest 2013
204
11

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.
Darren B Taichman, Joe Ornelas, Lorinda Chung, James R Klinger, Sandra Lewis, Jess Mandel, Harold I Palevsky, Stuart Rich, Namita Sood, Erika B Rosenzweig,[...]. Chest 2014
174
11

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
Zhi-Cheng Jing, Keyur Parikh, Tomas Pulido, Carlos Jerjes-Sanchez, R James White, Roblee Allen, Adam Torbicki, Kai-Feng Xu, David Yehle, Kevin Laliberte,[...]. Circulation 2013
224
11

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
R J Barst, L J Rubin, W A Long, M D McGoon, S Rich, D B Badesch, B M Groves, V F Tapson, R C Bourge, B H Brundage,[...]. N Engl J Med 1996
11

Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
Vallerie V McLaughlin, Anatoly Langer, Mary Tan, Philip J Clements, Ronald J Oudiz, Victor F Tapson, Richard N Channick, Lewis J Rubin. Chest 2013
88
11

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
G E D'Alonzo, R J Barst, S M Ayres, E H Bergofsky, B H Brundage, K M Detre, A P Fishman, R M Goldring, B M Groves, J T Kernis. Ann Intern Med 1991
11

The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.
N Nickel, H Golpon, M Greer, L Knudsen, K Olsson, V Westerkamp, T Welte, M M Hoeper. Eur Respir J 2012
237
11

Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
Pilar Escribano-Subias, Isabel Blanco, Manuel López-Meseguer, Carmen Jimenez Lopez-Guarch, Antonio Roman, Pilar Morales, María Jesús Castillo-Palma, Javier Segovia, Miguel A Gómez-Sanchez, Joan Albert Barberà. Eur Respir J 2012
244
11

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.
A Campo, S C Mathai, J Le Pavec, A L Zaiman, L K Hummers, D Boyce, T Housten, N Lechtzin, H Chami, R E Girgis,[...]. Eur Respir J 2011
113
11

Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis.
Annie Christine Lajoie, Gabriel Lauzière, Jean-Christophe Lega, Yves Lacasse, Sylvie Martin, Serge Simard, Sebastien Bonnet, Steeve Provencher. Lancet Respir Med 2016
142
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.